MoneyWorks4Me

The sales for the March 2025 quarter moved down to Rs. 2730.10 millions as compared to Rs. 2994.30 millions during the year-ago period.The Net Loss for the quarter ended March 2025 is Rs. -48.80 millions as compared to Net Loss of Rs. -2564.00 millions of corresponding quarter ended March 2024Operating profit surged to 485.40 millions from the corresponding previous quarter of 114.30 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 2730.10 2994.30 -8.82 12837.60 12889.20 -0.40 12837.60 12889.20 -0.40
Other Income 59.50 16.30 265.03 91.40 53.70 70.20 91.40 53.70 70.20
PBIDT 485.40 114.30 324.67 2129.80 -896.90 -337.46 2129.80 -896.90 -337.46
Interest 291.20 306.20 -4.90 1148.10 1059.70 8.34 1148.10 1059.70 8.34
PBDT 194.20 -1425.10 -113.63 981.70 -3853.00 -125.48 981.70 -3853.00 -125.48
Depreciation 243.00 251.00 -3.19 992.50 1030.30 -3.67 992.50 1030.30 -3.67
PBT -48.80 -1676.10 -97.09 -10.80 -4883.30 -99.78 -10.80 -4883.30 -99.78
TAX 0.00 887.90 0.00 0.00 785.40 0.00 0.00 785.40 0.00
Deferred Tax 0.00 887.90 0.00 0.00 785.40 0.00 0.00 785.40 0.00
PAT -48.80 -2564.00 -98.10 -10.80 -5668.70 -99.81 -10.80 -5668.70 -99.81
Equity 402.50 360.00 11.81 402.50 360.00 11.81 402.50 360.00 11.81
PBIDTM(%) 17.78 3.82 365.76 16.59 -6.96 -338.42 16.59 -6.96 -338.42
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..